NCT04604678View on ClinicalTrials.gov

Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 28, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

October 31, 2021

Conditions

Covid19

Interventions

DRUG

Metformin

Metformin at 1500 mg/day

DRUG

Naltrexone

Naltrexone at 4.5 mg/day (LDN)

Trial Locations (1)

48104

AgelessRx, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AgelessRx

INDUSTRY

NCT04604678 - Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 | Biotech Hunter | Biotech Hunter